Facebook X (Twitter) Instagram
    Facebook Instagram Threads
    Global BiodefenseGlobal Biodefense
    Subscribe
    • Featured News
    • Funding
    • Directory
    • Jobs
    • Events
    Global BiodefenseGlobal Biodefense
    Contracts + Grants

    RFQ – Development of Adeno-Associated Virus Particles

    By Global Biodefense StaffSeptember 10, 2014
    Share
    Facebook LinkedIn Reddit Email

    The U.S. Army Medical Research Institute of Chemical Defense (USAMRICD) is seeking quotations for the development and production of genetically modified adeno-associated virus (AAV) particles which can be used to express a protein of interest.

    AAV has been used to express proteins of interest in animal models for some time. The USAMRICD has a requirement to use this technology with a specific bioscavenger candidate of interest in support of countermeasure development.

    The contractor shall provide all personnel, equipment, supplies, facilities, transportation, tools, materials, supervision, and other items and non-personal services necessary to perform the development of the genetically altered AAV virus particles as defined by USAMRICD.

    Successful demonstration of the modified viral particle production will constitute the initial phase of the project with scaling of the process to allow the USAMRICD to order sufficient quantities for animal testing will comprise phase two.

    The period of performance will be for one base year with two option years.

    Further details are available under Solicitation Number: W81XWH-14-T-0467.  The response deadline is September 16, 2014.

    Animal Models Bioscavengers Request for Quotes USAMRICD
    Share. Facebook LinkedIn Reddit Email
    Previous ArticleDevelopment of Self-Powered Chemical and Biological Sensors
    Next Article Gates Foundation Commits $50 Million for Ebola Response

    Related Stories

    Jurata Thin Film and CastleVax Awarded Grant to Advance Thermostabilized COVID-19 Booster

    September 20, 2023

    Terrorism and the Pandemic: Weaponizing a Public Health Crisis

    September 20, 2023

    Mount Sinai to Lead Development of Pan-Coronavirus Vaccine Under New Federal Grant

    September 17, 2023

    NIAID Seeks to Improve Computational Models of Influenza Immunity

    September 15, 2023
    News Scan

    Biodefense Headlines – 19 September 2023

    News Scan September 19, 2023

    News highlights on health security threats and countermeasures curated by Global Biodefense This week’s selections include a global survey of gain-of-function research; funding of an mRNA mpox vaccine; Nipah virus outbreak in India; field detection of threat agents with acoustic…

    Upcoming Events

    Oct 3
    Virtual Event Virtual Event
    October 3 - October 5

    OneLab Summit 2023

    Oct 3
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships to Distribute, Dispense, and Administer Medical Countermeasures

    Oct 4
    Virtual Event Virtual Event
    10:00 am - 2:00 pm EDT

    Tunneling Nanotubes and Intracellular Protrusions Workshop

    Oct 12
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships for Acceptance and Uptake of Medical Countermeasures

    View Calendar

    Subscribe to Global Biodefense

    Get the latest news on pathogens and preparedness

    © 2023 Stemar Media Group LLC
    • About
    • Contact
    • Privacy
    • Subscribe

    Type above and press Enter to search. Press Esc to cancel.